Home β€Ί Stock analysis β€Ί PLSM

Pulsenmore (PLSM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

PLSM jumps 3.3% to $1.87. Closed at $1.87, +3.31% vs the prior close of $1.81. Day range $1.72–$1.87, opened at $1.75.

Last close$1.87+3.31%
Day range1.72–1.87
Open1.75
Volume25.34K
52-week range1.71–12.97
Avg volume (20d)45.56K

PLSM daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” PLSM jumps 3.3% to $1.87
Oct 15, 2026 β€” PLSM dips 0.5% to $1.81, a 6-month low
Oct 14, 2026 β€” PLSM slides 4.2% to $1.82
Oct 13, 2026 β€” PLSM jumps 4.4% to $1.90
Oct 12, 2026 β€” PLSM dips 1.6% to $1.82, a 6-month low
Oct 9, 2026 β€” PLSM slides 3.6% to $1.85, a 6-month low
Oct 8, 2026 β€” PLSM rises 0.7% to $1.92
Oct 7, 2026 β€” PLSM slides 11.8% to $1.91, a 6-month low
Oct 6, 2026 β€” PLSM dips 2.3% to $2.16, a 6-month low
Oct 5, 2026 β€” PLSM rises 0.9% to $2.21
Oct 2, 2026 β€” PLSM rises 0.7% to $2.19

PLSM latest news & SEC filings

Every SEC filing by or about PLSM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 14, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001493152-26-047022

Oct 14, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001493152-26-047021

Oct 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-046729

Oct 8, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001493152-26-046362

Sep 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-043034

Sep 8, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-041693

Sep 1, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-002851

Aug 31, 2026 Β· Form POS AM β€” POS AM filing

POS AM filing

Source: SEC EDGAR filing 0001493152-26-040823

Aug 31, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001493152-26-040818

Aug 31, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-040728

Aug 19, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-039108

Aug 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-038623

Aug 6, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-036334

Jul 13, 2026 Β· Form 424B3 β€” Prospectus / supplement for an offering or resale

Prospectus / supplement for an offering or resale

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001493152-26-033023

Jul 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001493152-26-032932

Things to know before you trade PLSM

PLSM market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20261.751.871.721.8725.34K
Oct 15, 20261.881.951.711.8132.30K
Oct 14, 20261.892.101.811.8240.40K
Oct 13, 20261.901.911.831.9039.10K
Oct 12, 20261.941.951.751.8217.70K
Oct 9, 20261.861.911.831.8516.10K
Oct 8, 20261.972.001.821.9233.50K
Oct 7, 20262.102.131.831.9174.40K
Oct 6, 20262.192.242.112.1637.10K
Oct 5, 20262.162.272.142.2129.10K
Oct 2, 20262.212.282.142.1924.30K
Oct 1, 20262.272.482.142.1743.00K
Sep 30, 20262.262.262.102.2238.60K
Sep 29, 20262.272.361.972.1953.40K
Sep 28, 20262.402.552.232.2832.20K
Sep 25, 20262.462.612.402.4162.10K
Sep 24, 20262.522.632.402.57101.60K
Sep 23, 20262.402.642.352.4498.00K
Sep 22, 20262.412.472.292.3786.00K
Sep 21, 20262.332.392.282.3326.90K

About Pulsenmore

Pulsenmore (PLSM) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in ISRAEL. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 2064764.

PLSM board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Jonathan AderethDirectorMar 18, 2026
Racheli Guz-LaviDirectorMar 18, 2026
Hagai ItkinDirectorMar 18, 2026
Anat LoewensteinDirectorMar 18, 2026
Linda MessalemDirectorMar 18, 2026
Elazar SonnenscheinChief Executive OfficerMar 18, 2026

Executive officers

NameTitleLatest filing
Michael HamelsdorfGC & Corporate SecretaryMar 18, 2026
Eran HirshChief Financial OfficerMar 18, 2026
Meir ShmouelyVP Software DevelopmentMar 18, 2026
Elazar SonnenscheinChief Executive OfficerMar 18, 2026
Minelu SonnenscheinVP R&DMar 18, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

PLSM financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

PLSM earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on PLSM

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.